tiprankstipranks
Trending News
More News >
Cytek Biosciences reports Q1 EPS (9c) vs. (5c) last year
PremiumThe FlyCytek Biosciences reports Q1 EPS (9c) vs. (5c) last year
16d ago
Cytek Biosciences cuts FY25 revenue view to $196M-$210M from $204M-$212M
Premium
The Fly
Cytek Biosciences cuts FY25 revenue view to $196M-$210M from $204M-$212M
16d ago
Cytek Biosciences: Hold Rating Amid Revenue Decline and Macroeconomic Uncertainties
Premium
Ratings
Cytek Biosciences: Hold Rating Amid Revenue Decline and Macroeconomic Uncertainties
2M ago
Cytek Biosciences reports Q4 revenue $57.48M, consensus $59.38M
PremiumThe FlyCytek Biosciences reports Q4 revenue $57.48M, consensus $59.38M
3M ago
Cytek Biosciences sees FY25 revenue $204M-$212M, consensus $216.52M
Premium
The Fly
Cytek Biosciences sees FY25 revenue $204M-$212M, consensus $216.52M
3M ago
Cytek Biosciences price target raised to $5.25 from $4.50 at Goldman Sachs
Premium
The Fly
Cytek Biosciences price target raised to $5.25 from $4.50 at Goldman Sachs
4M ago
Cytek Biosciences sees FY24 revenue $200M-$201M, consensus $204.71M
PremiumThe FlyCytek Biosciences sees FY24 revenue $200M-$201M, consensus $204.71M
4M ago
Cytek Biosciences board approves $50M stock repurchase program
Premium
The Fly
Cytek Biosciences board approves $50M stock repurchase program
5M ago
Cytek Biosciences price target raised to $8.50 from $8 at Piper Sandler
Premium
The Fly
Cytek Biosciences price target raised to $8.50 from $8 at Piper Sandler
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100